FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Questions Data in Stealth NDA for Barth Syndrome

FDA reviewers appear unconvinced that a Stealth BioTherapeutics NDA for elamipretide, a mitochondria-targeted therapy for treating Barth syndrome, con...

latest-news-card-1
Medical Devices

Covid/Flu Rapid Test Authorized for OTC Use

FDA grants a de novo marketing authorization for over-the-counter Healgen Rapid Check Covid-19/Flu A&B Antigen Test.

latest-news-card-1
Medical Devices

Workshop Advances Brain/Computer Interface Assessment

FDA releases the transcript from a two-day workshop held in conjunction with NIH on developing clinical outcome assessments to demonstrate the risks a...

Human Drugs

Two Stakeholder Comments on BCG-Unresponsive Guide

Two stakeholders recommend changes to an FDA draft guidance on treatment development for Bacillus Calmette-Guerin-Unresponsive Nonmuscle Invasive Blad...

latest-news-card-1
Human Drugs

Significant CGMP Violations at MMC Healthcare

FDA warns Indias MMC Healthcare about CGMP violations in its production of finished drugs.

latest-news-card-1
Human Drugs

Hospital Group Seeks FDA Actions in IV Solution Shortages

The American Hospital Association asks the Biden Administration to require FDA to take immediate actions to increase the supply of intravenous (IV) so...

latest-news-card-1
Human Drugs

Woodcock Joins Board at Drug Repurposing Nonprofit

Former FDA principal deputy commissioner Janet Woodcock joins the board of directors at Every Cure, a nonprofit organization that looks at repurposing...

latest-news-card-1
Medical Devices

Respironics Recalls Trilogy Ventilators Over Nebulizers

Philips Respironics recalls (Class 1 device correction) its Trilogy Evo, Trilogy Evo O2, Trilogy Evo Universal, and Trilogy EV300 ventilators regardin...

latest-news-card-1
Human Drugs

Clinical Hold Slapped on Kezar Lupus Trial

FDA orders a clinical hold on Kezar Life Sciences IND for zetomipzomib and its investigational use in treating lupus nephritis.

latest-news-card-1
Human Drugs

Sublocade Priority Review for Expanded Labeling

FDA awards a priority review for an Indivior prior approval supplement for Sublocade (buprenorphine) extended-release injection for treating moderate ...